156 related articles for article (PubMed ID: 15766564)
1. Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily.
Barbosa-Sicard E; Markovic M; Honeck H; Christ B; Muller DN; Schunck WH
Biochem Biophys Res Commun; 2005 Apr; 329(4):1275-81. PubMed ID: 15766564
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450.
Fer M; Dréano Y; Lucas D; Corcos L; Salaün JP; Berthou F; Amet Y
Arch Biochem Biophys; 2008 Mar; 471(2):116-25. PubMed ID: 18206980
[TBL] [Abstract][Full Text] [Related]
3. Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids.
Konkel A; Schunck WH
Biochim Biophys Acta; 2011 Jan; 1814(1):210-22. PubMed ID: 20869469
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450-dependent metabolism of eicosapentaenoic acid in the nematode Caenorhabditis elegans.
Kulas J; Schmidt C; Rothe M; Schunck WH; Menzel R
Arch Biochem Biophys; 2008 Apr; 472(1):65-75. PubMed ID: 18282462
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
Yao HT; Chang YW; Lan SJ; Chen CT; Hsu JT; Yeh TK
Life Sci; 2006 Nov; 79(26):2432-40. PubMed ID: 16978661
[TBL] [Abstract][Full Text] [Related]
6. Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine.
Ring BJ; Eckstein JA; Gillespie JS; Binkley SN; VandenBranden M; Wrighton SA
J Pharmacol Exp Ther; 2001 Jun; 297(3):1044-50. PubMed ID: 11356927
[TBL] [Abstract][Full Text] [Related]
7. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform.
Zeldin DC; DuBois RN; Falck JR; Capdevila JH
Arch Biochem Biophys; 1995 Sep; 322(1):76-86. PubMed ID: 7574697
[TBL] [Abstract][Full Text] [Related]
9. Structural and energetic analysis to provide insight residues of CYP2C9, 2C11 and 2E1 involved in valproic acid dehydrogenation selectivity.
Bello M; Mendieta-Wejebe JE; Correa-Basurto J
Biochem Pharmacol; 2014 Jul; 90(2):145-58. PubMed ID: 24794636
[TBL] [Abstract][Full Text] [Related]
10. Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9.
Daikh BE; Lasker JM; Raucy JL; Koop DR
J Pharmacol Exp Ther; 1994 Dec; 271(3):1427-33. PubMed ID: 7996455
[TBL] [Abstract][Full Text] [Related]
11. cDNA-directed expression of two allelic variants of cytochrome P450 2C11 using COS1 and SF21 insect cells.
Biagini C; Celier C
Arch Biochem Biophys; 1996 Feb; 326(2):298-305. PubMed ID: 8611037
[TBL] [Abstract][Full Text] [Related]
12. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
Karam WG; Goldstein JA; Lasker JM; Ghanayem BI
Drug Metab Dispos; 1996 Oct; 24(10):1081-7. PubMed ID: 8894508
[TBL] [Abstract][Full Text] [Related]
13. Sex difference in the principal cytochrome P-450 for tributyltin metabolism in rats.
Ohhira S; Enomoto M; Matsui H
Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):32-8. PubMed ID: 16039681
[TBL] [Abstract][Full Text] [Related]
14. Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids.
Arnold C; Markovic M; Blossey K; Wallukat G; Fischer R; Dechend R; Konkel A; von Schacky C; Luft FC; Muller DN; Rothe M; Schunck WH
J Biol Chem; 2010 Oct; 285(43):32720-32733. PubMed ID: 20732876
[TBL] [Abstract][Full Text] [Related]
15. Eicosanoid formation by a cytochrome P450 isoform expressed in the pharynx of Caenorhabditis elegans.
Kosel M; Wild W; Bell A; Rothe M; Lindschau C; Steinberg CE; Schunck WH; Menzel R
Biochem J; 2011 May; 435(3):689-700. PubMed ID: 21309752
[TBL] [Abstract][Full Text] [Related]
16. Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid.
Schwarz D; Kisselev P; Ericksen SS; Szklarz GD; Chernogolov A; Honeck H; Schunck WH; Roots I
Biochem Pharmacol; 2004 Apr; 67(8):1445-57. PubMed ID: 15041462
[TBL] [Abstract][Full Text] [Related]
17. Differential contribution of renal cytochrome P450 enzymes to kidney endothelial dysfunction and vascular oxidative stress in obesity.
Muñoz M; López-Oliva E; Pinilla E; Rodríguez C; Martínez MP; Contreras C; Gómez A; Benedito S; Sáenz-Medina J; Rivera L; Prieto D
Biochem Pharmacol; 2022 Jan; 195():114850. PubMed ID: 34822809
[TBL] [Abstract][Full Text] [Related]
18. In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily.
Usmani KA; Karoly ED; Hodgson E; Rose RL
Drug Metab Dispos; 2004 Mar; 32(3):333-9. PubMed ID: 14977868
[TBL] [Abstract][Full Text] [Related]
19. Ontogenesis of CYP2C-dependent arachidonic acid metabolism in the human liver: relationship with sudden infant death syndrome.
Tréluyer JM; Benech H; Colin I; Pruvost A; Chéron G; Cresteil T
Pediatr Res; 2000 May; 47(5):677-83. PubMed ID: 10813596
[TBL] [Abstract][Full Text] [Related]
20. Characterization of recombinant CYP2C11: a vitamin D 25-hydroxylase and 24-hydroxylase.
Rahmaniyan M; Patrick K; Bell NH
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E753-60. PubMed ID: 15585593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
